✦ LIBER ✦

Subchronic toxicity and toxicokinetics of LZB, a new proton pump inhibitor, after 13-week repeated oral administration in dogs

✍ Scribed by Yu Mao; Xiaodong Zhang; Li Li; Bojun Yuan; Guocai Lu

Book ID: 113965266
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 866 KB
Volume: 50
Category: Article
ISSN: 0273-2300
DOI: 10.1016/j.yrtph.2007.10.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subacute toxicity and toxicokinetics of

Subacute toxicity and toxicokinetics of CJ-10882, a type IV phosphodiesterase inhibitor, after 4-week repeated oral administration in dogs

✍ Junghee Han; Ho-Chul Shin; Jong-Choon Kim; Byungbae Kim 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 350 KB

Subacute toxicities and toxicokinetics o

Subacute toxicities and toxicokinetics of a new erectogenic, DA-8159, after single and 4-week repeated oral administration in dogs

✍ Hyun J. Shim; Eun J. Lee; Jung H. Kim; Soon H. Kim; Jong W. Kwon; Won B. Kim; Sh 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

The subacute toxicities and toxicokinetics of a new erectogenic, DA-8159, were evaluated after single (at the 1st day) and 4-week (at the 28th day) oral administration of the drug, in doses of 0 (to serve as a control), 12.5, 50 and 200 mg/kg/day, to male and female dogs (n ¼ 3 for male and female d

Subacute toxicities and toxicokinetics o

Subacute toxicities and toxicokinetics of DA-8159, a new phosphodiesterase type V inhibitor, after single and 4-Week repeated oral administration in rats

✍ Hyun J. Shim; Yu C. Kim; Ji M. Jang; Kyung J. Park; Dong H. Kim; Kyung K. Kang; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

## Abstract The subacute toxicities (10 male and 10 female rats at each dose) and the toxicokinetics (5 male rats at each dose) of DA‐8159, a new phosphodiesterase type V (PDE V) inhibitor, were evaluated after single (at day 1) and 4‐week (at day 28) oral administration of the drug at doses of 0 (

Pharmacokinetics of a new reversible pro

Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: hepatic first-pass effect in rats

✍ Kye S. Han; Yoon G. Kim; Joong K. Yoo; Jong W. Lee; Myung G. Lee 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 1 views

The pharmacokinetics of YH1885 were evaluated after intravenous (iv) and oral administrations of the drug to rats and dogs. The reason for the low extent of bioavailability (F) of YH1885 after oral administration of the drug to rats and the absorption of the drug from various rat gastrointestinal (G

Gastrointestinal Absorption of a New Rev

Gastrointestinal Absorption of a New Reversible Proton Pump Inhibitor, YJA-20379-8, and its Pharmacokinetics after Oral Administration in Acetic Acid-induced Gastric Ulcer in Rats

✍ SU Y. CHUNG; KYE S. HAN; HO J. KIM; JONGHAN KIM; MAN S. CHANG; MYUNG G. LEE 📂 Article 📅 1999 🏛 Pharmaceutical Press 🌐 English ⚖ 87 KB